Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Jupiter Neurosciences Inc (JUNS)

Jupiter Neurosciences Inc (JUNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Jupiter Neurosciences Inc 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 USA

https://jupiterneurosciences.com Employees: 4 P: 561-406-6154

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Jupiter Neurosciences Inc. is a clinical-stage pharmaceutical company focused on treating neuroinflammation, with a current focus on CNS disorders and rare diseases. The Company's pipeline is focused broadly on CNS disorder and includes indications such as Alzheimer's Disease, Parkinson's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia and MELAS. Jupiter Neurosciences Inc. is based in Jupiter, Florida.

Key Statistics

Overview:

Market Capitalization, $K 14,455
Enterprise Value, $K 10,685
Shares Outstanding, K 34,426
Float, K 16,938
% Float 49.20%
Short Interest, K 238
Short Float 0.69%
Days to Cover 2.28
Short Volume Ratio 0.57
% of Insider Shareholders 50.80%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -2,440 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,290 K
EBIT, $ -7,570 K
EBITDA, $ -7,530 K

Growth:

1-Year Return -41.36%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 11/14/25
Next Earnings Date 03/27/26 [--]
Earnings Per Share ttm -0.24
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -250.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

JUNS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 7.55
Price/Earnings to Growth N/A
Return-on-Equity % -351.99%
Return-on-Assets % -171.62%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -8.76
60-Month Beta 2.62
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar